Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma with GEMCAP and mFOLFIRINOX Regimens: Adverse Events and Long-Term Outcomes. (2026). Voprosy Onkologii, 72(1), OF-2421. https://doi.org/10.37469/0507-3758-2026-72-1-OF-2421